Symbols

Symbols

VCYT

VCYT

Veracyte CFO Chambers sells 7000 shares at $41/share on Nov. 5.

Thursday Nov 06, 2025

Veracyte shares surge 27.46% intraday as Q3 earnings, revenue exceed estimates and 2025 guidance raised.

Veracyte's Hold Recommendation Maintained by Canaccord Genuity, Analyst Price Forecast Suggests 6.79% Downside

Wednesday Nov 05, 2025

Veracyte: UBS maintains Buy, raises PT to $48 from $42.

Veracyte shares surge 12.13% after-hours as Q3 earnings and revenue exceed estimates, with raised 2025 guidance.

Veracyte: Canaccord Genuity Raises PT to $43 from $40, Maintains Hold Rating

Veracyte shares jump 19.96% intraday after Q3 revenue and EPS beat estimates, guidance raised, and analyst price targets increased by Needham and Canaccord.

Veracyte: Guggenheim Raises Buy Rating, PT to $45 from $40.

It looks like you sent an empty JSON object. Could you clarify what you're asking for or provide more details? I'm here to help, but I need some information to work with! .

Veracyte: Needham Raises PT to $44, Maintains Buy Rating

Veracyte shares surge 11.16% premarket after Q3 revenue jumps 14% to $131.9M and EBITDA margin hits 30%.

Tuesday Nov 04, 2025

Veracyte Raises 2025 Revenue Outlook to $510M, Boosts Growth Investments

Veracyte shares surge 10.74% after-hours after reporting 14% revenue growth and raising 2025 guidance.

Monday Nov 03, 2025

Veracyte's 15-minute chart triggers KDJ Death Cross, bearish marubozu signal.

Friday Oct 31, 2025

Veracyte: 15-minute chart shows MACD Death Cross, Bollinger Bands Narrowing

Veracyte: 15-minute chart shows MACD Death Cross, Bollinger Bands Narrowing

Thursday Oct 30, 2025

Veracyte's 15min chart triggers MACD Death Cross, Bollinger Bands Narrowing

Wednesday Oct 29, 2025

Veracyte's 15-minute chart triggers KDJ Death Cross, bearish Marubozu candlestick pattern.

Veracyte's 15-min chart shows Bollinger Bands expanding upward and downward.

Veracyte's 15-min chart shows Bollinger Bands expanding upward and downward.